Ribozyme mediated suppression of vascular endothelial growth factor gene expression enhances matrix metalloproteinase 1 expression in a human hepatocellular carcinoma cell line

被引:2
作者
Kamochi, J
Tokunaga, T
Morino, F
Nagata, J
Tomii, Y
Abe, Y
Hatanaka, H
Kijima, H
Yamazaki, H
Watanabe, N
Matsuzaki, S
Ueyama, Y
Nakamura, M [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Pathol, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Kanagawa 2591193, Japan
关键词
VEGF expression; ribozyme; MMP1; hepatocellular carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The levels of expression of various genes were altered in cellular transformants with manipulation of expression of single genes. Vascular endothelial growth factor A (VEGF-A) is a key molecule for tumor progression, although it is unclear how VEGF-A expression regulates various genes. Multiple gene expression levels were evaluated using cDNA arrays in a human hepatocellular carcinoma cell line (HLF) with suppression of the VEGF-A gene by anti-VEGF-A ribozyme (alphaVRz). The ribozyme-mediated suppression of VEGF-A gene solely up-regulated matrix metalloproteinase 1 (MMP1) gene level in HLF/alphaVRz. Levels of expression of other members of MMP family or tissue inhibitors of MMPs did not show any alteration. These results suggested that intracellular suppression of VEGF-A gene was specifically linked to up-regulation of MMP1 in human hepatocellular carcinoma cells.
引用
收藏
页码:81 / 84
页数:4
相关论文
共 24 条
  • [1] Arii S, 2001, J Hepatobiliary Pancreat Surg, V8, P397, DOI 10.1007/s005340100000
  • [2] Bruns CJ, 2000, CANCER, V89, P488, DOI 10.1002/1097-0142(20000801)89:3<488::AID-CNCR3>3.3.CO
  • [3] 2-O
  • [4] PRIMARY HEPATOCELLULAR-CARCINOMA AND HEPATITIS-B VIRUS-INFECTION IN KOREA
    CHUNG, WK
    SUN, HS
    PARK, DH
    MINUK, GY
    HOOFNAGLE, JH
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1983, 11 (02) : 99 - 104
  • [5] Drevs J, 2000, CANCER RES, V60, P4819
  • [6] Ito T, 1999, MODERN PATHOL, V12, P669
  • [7] Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma
    Lee, YH
    Tokunaga, T
    Oshika, Y
    Suto, R
    Yanagisawa, K
    Tomisawa, M
    Fukuda, H
    Nakano, H
    Abe, S
    Tateishi, A
    Kijima, H
    Yamazaki, H
    Tamaoki, N
    Ueyama, Y
    Nakamura, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (07) : 1089 - 1093
  • [8] Systemic therapy for hepatocellular carcinoma
    Leung, TWT
    Johnson, PJ
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (05) : 514 - 520
  • [9] Morino F, 2000, INT J ONCOL, V17, P495
  • [10] Matrix metalloproteinases: Biologic activity and clinical implications
    Nelson, AR
    Fingleton, B
    Rothenberg, ML
    Matrisian, LM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1135 - 1149